Market Forecast By Prescription Type (Prescription Drugs, Over-the-Counter Drugs), By Drug Type (Branded Drugs, Generic Drugs, Branded Generic Drugs), By Drug Class (Small Molecules, Biologics, Biosimilars), By Indication (Cardiovascular Diseases, Immunology, Respiratory Diseases, Neurological Diseases, Infectious Diseases, Skin Diseases), By Mode of Administration (Topical, Oral, Injectable, Intra-nasal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
| Product Code: ETC8372768 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the Mongolia Pharmaceutical Market is projected to grow at a compound annual growth rate (CAGR) of 9.9% during the forecast period from 2026 to 2032.
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Year | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 8.3 | Increasing expenditure on healthcare and high risks of chronic diseases. |
| 2022 | 8.5 | Growth in infrastructure of healthcare, expansion of retail and hospital pharmacies. |
| 2023 | 8.7 | Reforms in government healthcare and high awareness of healthcare. |
| 2024 | 9 | Rising demand for generic and over-the-counter drugs improves accessibility to medicines. |
| 2025 | 9.3 | New synonyms in drug delivery systems and more international collaborations for new therapies. |
The Mongolia Pharmaceutical Market report thoroughly covers the market by prescription type, drug type, drug class, indication, mode of administration, and distribution channel. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | Mongolia Pharmaceutical Market |
| Forecast period | 2026–2032 |
| CAGR | 9.9% |
| Growing Sector | Healthcare & Pharmaceuticals |
Mongolia Pharmaceutical Market is expected to witness major growth as it is driven by the high risks of chronic diseases, increased awareness about healthcare, and ongoing improvements in healthcare infrastructure. The growing partnerships between local and international pharmaceutical companies creates a developed drug portfolio in Mongolia. The market has a strong growth potential due to the high demand for prescription and over-the-counter medications across all demographics. New government programs for access to affordable medicine, along with the increasing usage of generic drugs, biosimilars, and over-the-counter (OTC) medicines also supports the growth of the Mongolia Pharmaceutical Industry.
Below mentioned are some prominent drivers and their impact on the Mongolia Pharmaceutical Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing Chronic Diseases | Prescription Drugs, OTC Drugs | Rising risks of diseases such as cardiovascular diseases, diabetes, and respiratory illnesses is creating increased demand for pharmaceutical products. |
| Government Healthcare Programs | All Segments | Programs like the National Health Insurance Scheme, drug subsidies, and access to essential medicines have helped in reducing prices. |
| Expanding Healthcare Infrastructure | All Segments | Growth in the healthcare sector, including developments of new hospital and pharmacy and also improves availability of drug in urban and rural areas. |
| Growing Health Awareness | All Segments | Increase health education creates high demand for both preventive care and prescription medications. |
| International Collaborations | Branded Drugs, Biologics | Collaborations with global pharmaceutical companies introduce better medicines and improving the quality of available drugs. |
Mongolia Pharmaceutical Market Size is expected to grow at a CAGR of 9.9% from 2026 to 2032. Some important key drivers include the high risk of chronic diseases, government healthcare programs, expansion of healthcare infrastructure, and increased collaborations between local and international pharmaceutical companies. The market is also supported by the increased usage of generics and biosimilars, which provide affordable alternatives to branded medicines. The market has a strong growth potential due to the high demand for prescription and over-the-counter medications across all demographics. The increasing awareness in healthcare sector and higher spending are expected to drive major Mongolia Pharmaceutical Market Growth.
Below mentioned are some major restraints and their influence on the Mongolia Pharmaceutical Market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| High Cost of Branded Drugs | Branded Drugs | High prices may reduce sales of branded drugs, especially for those consumers who have lower-income. |
| Regulatory Compliance | All Segments | Difficult laws and drug approval processes can delay the production of new medicines. |
| Limited Local Manufacturing | Branded and Biologics | Heavy dependence on imported medicines may increases prices and cause disruptions in supply chain. |
| Economic Constraints | All Segments | Lower income levels of many consumers may reduce the sales of medicines and affects overall market growth. |
| Counterfeit Drugs | OTC and Generic Drugs | Presence of fraud drugs can also reduce consumer’s trust in the pharmaceutical market and affect both consumers and healthcare providers. |
Mongolia Pharmaceutical Market faces many challenges, such as the high prices of branded drugs, regulatory difficulties, and less capacity of local drug manufacturing. The market’s heavy dependence on imported medicines increases the pricing challenges, and fraud drugs also reduce the consumer’s trust in the industry. Less access to advanced therapies in rural areas and logistical difficulties in drug distribution are additional difficulties in this market’s growth. The lack of skilled healthcare professionals and pharmacists in remote areas also limits the distribution and proper use of medications. Economic difficulties in lower-income segments of the population, may also reduce access to essential medicines and restricts overall market growth.
Key trends shaping the Mongolia Pharmaceutical Market include:
Some major investment opportunities in Mongolia Pharmaceutical Industry are:
Here are the leading companies in the Mongolia pharmaceutical market:
| Company Name | Sanofi S.A. |
| Headquarters | Paris, France |
| Established | 1973 |
| Website | Click Here |
Sanofi is a global pharmaceutical leader with a strong presence in Mongolia, offering a variety of branded and generic drugs, especially in therapeutic areas like cardiovascular and immunology.
| Company Name | Novartis AG |
| Headquarters | Basel, Switzerland |
| Established | 1996 |
| Website | Click Here |
Novartis focuses on providing innovative medicines and biosimilars in Mongolia, particularly for oncology, respiratory, and neurological treatments.
| Company Name | GlaxoSmithKline (GSK) |
| Headquarters | Brentford, UK |
| Established | 2000 |
| Website | Click Here |
GSK offers a wide range of vaccines, prescription drugs, and over-the-counter (OTC) products in Mongolia, with a special focus on respiratory diseases and infectious diseases.
| Company Name | Cipla Ltd. |
| Headquarters | Mumbai, India |
| Established | 1935 |
| Website | Click Here |
Cipla is a key player in the Mongolian pharmaceutical market, particularly known for its affordable generic medicines in the areas of cardiovascular, respiratory, and chronic disease management.
| Company Name | Mongolian Pharmaceuticals LLC |
| Headquarters | Ulaanbaatar, Mongolia |
| Established | 1994 |
| Website | Click Here |
As a prominent local pharmaceutical manufacturer, Mongolian Pharmaceuticals LLC produces a range of branded and generic medicines, catering to both the domestic market and export.
According to Lakshita, Senior Research Analyst, 6Wresearch, they have started many programs that strengthen the pharmaceutical sector and improve healthcare for its citizens. The National Health Insurance Scheme make sures that individuals have access to affordable healthcare and essential medicines. The Medicines Regulatory Authority plays an important role by overseeing the approval process for drugs, ensuring their safety and efficacy before they enter the market. To reduce dependence on imports from other countries and support domestic production. The government increase public-private partnerships by collaborating with international pharmaceutical companies to introduce new drugs and cutting-edge technologies this also improve the sales of advanced therapies in the country.
Mongolia Pharmaceutical Market is expected to maintain its steady growth in the upcoming years as it is driven by high risk of chronic diseases, expanding government healthcare programs, and the continuous development of healthcare infrastructure. The increasing demand for generic and biosimilar drugs will also increase this market’s demand in the long run. The rise of digital pharmacies and telehealth services, will improve accessibility of medicine, especially in remote areas. Mongolia Pharmaceutical Industry has great demand for prescription and over-the-counter drugs, so the sector is all set to become an important player in the global healthcare industry.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Lakshita, Senior Research Analyst, 6Wresearch, Prescription Drugs dominate the Mongolia market due to increasing risk of chronic and lifestyle-related diseases such as including cardiovascular, diabetes, and immunological disorders.
Branded Generic Drugs are dominating, as they provide a balance between affordability and quality. They are widely famous in Mongolia for treating chronic conditions while keeping prices less, driving strong use in hospitals and retail pharmacies.
Small Molecules dominate the Mongolia Pharmaceutical Market Share, due to their wide usage in chronic and acute conditions, ease of manufacturing, and price range compared to biologics. Biologics and biosimilars demand are increasing particularly in immunology.
Cardiovascular Diseases dominate this segment due to high numbers in aging population and rising lifestyle diseases. Other indications such as immunology and respiratory diseases are also growing with increased awareness and treatment options.
Oral drugs dominate due to their ease of use, patient compliance, and cost efficiency. Injectable and topical formulations are used in therapies, while intra-nasal and other methods remain limited but innovative.
Retail Pharmacies dominate as the main source for medicines due to their easy accessibility, convenience, and strong demand in urban and semi-urban areas. Hospital pharmacies are also important for prescription drugs.
The report offers a comprehensive study of the following Mongolia Pharmaceutical Market segments:
|
1 Executive Summary |
|
2 Introduction |
|
2.1 Key Highlights of the Report |
|
2.2 Report Description |
|
2.3 Market Scope & Segmentation |
|
2.4 Research Methodology |
|
2.5 Assumptions |
|
3 Mongolia Pharmaceutical Market Overview |
|
3.1 Mongolia Country Macro Economic Indicators |
|
3.2 Mongolia Pharmaceutical Market Revenues & Volume, 2022 & 2032F |
|
3.3 Mongolia Pharmaceutical Market - Industry Life Cycle |
|
3.4 Mongolia Pharmaceutical Market - Porter's Five Forces |
|
3.5 Mongolia Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2022 & 2032F |
|
3.6 Mongolia Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
|
3.7 Mongolia Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
|
3.8 Mongolia Pharmaceutical Market Revenues & Volume Share, By Indication, 2022 & 2032F |
|
3.9 Mongolia Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
|
3.10 Mongolia Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
|
4 Mongolia Pharmaceutical Market Dynamics |
|
4.1 Impact Analysis |
|
4.2 Market Drivers |
|
4.2.1 Increasing healthcare expenditure in Mongolia |
|
4.2.2 Growing awareness about healthcare and wellness |
|
4.2.3 Rising prevalence of chronic diseases in the population |
|
4.3 Market Restraints |
|
4.3.1 Regulatory challenges and stringent approval processes |
|
4.3.2 Limited healthcare infrastructure and access to services |
|
5 Mongolia Pharmaceutical Market Trends |
|
6 Mongolia Pharmaceutical Market, By Types |
|
6.1 Mongolia Pharmaceutical Market, By Prescription Type |
|
6.1.1 Overview and Analysis |
|
6.1.2 Mongolia Pharmaceutical Market Revenues & Volume, By Prescription Type, 2022- 2032F |
|
6.1.3 Mongolia Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2022- 2032F |
|
6.1.4 Mongolia Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2022- 2032F |
|
6.2 Mongolia Pharmaceutical Market, By Drug Type |
|
6.2.1 Overview and Analysis |
|
6.2.2 Mongolia Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2022- 2032F |
|
6.2.3 Mongolia Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2022- 2032F |
|
6.2.4 Mongolia Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2022- 2032F |
|
6.3 Mongolia Pharmaceutical Market, By Drug Class |
|
6.3.1 Overview and Analysis |
|
6.3.2 Mongolia Pharmaceutical Market Revenues & Volume, By Small Molecules, 2022- 2032F |
|
6.3.3 Mongolia Pharmaceutical Market Revenues & Volume, By Biologics, 2022- 2032F |
|
6.3.4 Mongolia Pharmaceutical Market Revenues & Volume, By Biosimilars, 2022- 2032F |
|
6.4 Mongolia Pharmaceutical Market, By Indication |
|
6.4.1 Overview and Analysis |
|
6.4.2 Mongolia Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2022- 2032F |
|
6.4.3 Mongolia Pharmaceutical Market Revenues & Volume, By Immunology, 2022- 2032F |
|
6.4.4 Mongolia Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2022- 2032F |
|
6.4.5 Mongolia Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2022- 2032F |
|
6.4.6 Mongolia Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2022- 2032F |
|
6.4.7 Mongolia Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2022- 2032F |
|
6.5 Mongolia Pharmaceutical Market, By Mode of Administration |
|
6.5.1 Overview and Analysis |
|
6.5.2 Mongolia Pharmaceutical Market Revenues & Volume, By Topical, 2022- 2032F |
|
6.5.3 Mongolia Pharmaceutical Market Revenues & Volume, By Oral, 2022- 2032F |
|
6.5.4 Mongolia Pharmaceutical Market Revenues & Volume, By Injectable, 2022- 2032F |
|
6.5.5 Mongolia Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2022- 2032F |
|
6.5.6 Mongolia Pharmaceutical Market Revenues & Volume, By Others, 2022- 2032F |
|
6.6 Mongolia Pharmaceutical Market, By Distribution Channel |
|
6.6.1 Overview and Analysis |
|
6.6.2 Mongolia Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2022- 2032F |
|
6.6.3 Mongolia Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2022- 2032F |
|
6.6.4 Mongolia Pharmaceutical Market Revenues & Volume, By Drug Stores, 2022- 2032F |
|
6.6.5 Mongolia Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2022- 2032F |
|
7 Mongolia Pharmaceutical Market Import-Export Trade Statistics |
|
7.1 Mongolia Pharmaceutical Market Export to Major Countries |
|
7.2 Mongolia Pharmaceutical Market Imports from Major Countries |
|
8 Mongolia Pharmaceutical Market Key Performance Indicators |
|
8.1 Percentage increase in the number of healthcare facilities in Mongolia |
|
8.2 Adoption rate of innovative pharmaceutical products in the market |
|
8.3 Average prescription volume per capita in Mongolia |
|
9 Mongolia Pharmaceutical Market - Opportunity Assessment |
|
9.1 Mongolia Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2022 & 2032F |
|
9.2 Mongolia Pharmaceutical Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
|
9.3 Mongolia Pharmaceutical Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
|
9.4 Mongolia Pharmaceutical Market Opportunity Assessment, By Indication, 2022 & 2032F |
|
9.5 Mongolia Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
|
9.6 Mongolia Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
|
10 Mongolia Pharmaceutical Market - Competitive Landscape |
|
10.1 Mongolia Pharmaceutical Market Revenue Share, By Companies, 2022 & 2032 |
|
10.2 Mongolia Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
|
11 Company Profiles |
|
12 Recommendations |
|
13 Disclaimer |